Gene: FAM199X
Official Full Name: family with sequence similarity 199, X-linkedprovided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25986 | FAM199X Knockout cell line (HeLa) | Human | FAM199X | 1:3~1:6 | Negative | Online Inquiry |
KO25987 | FAM199X Knockout cell line (HCT 116) | Human | FAM199X | 1:2~1:4 | Negative | Online Inquiry |
KO25988 | FAM199X Knockout cell line (HEK293) | Human | FAM199X | 1:3~1:6 | Negative | Online Inquiry |
KO25989 | FAM199X Knockout cell line (A549) | Human | FAM199X | 1:3~1:4 | Negative | Online Inquiry |
FAM199X Gene Knockout Cell Lines represent a revolutionary tool in genetic research, specifically designed to facilitate the study of the FAM199X gene's functions and its implications in various biological processes and disease mechanisms. These cell lines have been meticulously engineered using CRISPR-Cas9 technology to create specific gene knockouts, allowing researchers to investigate the role of FAM199X without the confounding effects of its normal expression. By removing this gene, scientists can uncover its contributions to cellular pathways and clarify how mutations may influence pathological conditions.
The primary function of FAM199X Gene Knockout Cell Lines is to provide a robust model for gene function studies, drug discovery, and therapeutic development. The systematic gene disruption promotes an in-depth analysis of the cellular responses to stimuli, revealing insights into gene regulation, protein interactions, and metabolic pathways. The high precision of the CRISPR-Cas9 gene-editing mechanism minimizes off-target effects, ensuring that results are both reliable and reproducible.
The scientific importance of employing FAM199X Gene Knockout Cell Lines extends to a variety of applications in both fundamental and applied research settings. This includes developmental biology, oncogenesis, neurobiology, and potential gene therapy avenues, making it an invaluable asset for those studying gene functions associated with disease states or exploring novel treatments.
Compared to traditional methods of gene silencing, such as siRNA or shRNA interventions, FAM199X Gene Knockout Cell Lines offer distinct advantages. Their stable knockouts provide a consistent and long-term platform for experimentation without the transient effects inherent in other techniques. This stability, combined with the accuracy of CRISPR-Cas9, significantly enhances experimental depth and allows for longitudinal studies that can yield more comprehensive insights.
For researchers and clinicians looking to deepen their understanding of genetic contributions to health and disease, the FAM199X Gene Knockout Cell Lines deliver an unparalleled resource that supports innovative research efforts. These cell lines not only streamline experimental workflows but also ultimately contribute to knowledge that could lead to breakthroughs in patient care and therapeutic strategies.
With a commitment to scientific advancement and a portfolio of cutting-edge biological products, our company is dedicated to empowering researchers and improving outcomes in health and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.